Cargando…
Early use of tocilizumab in respiratory failure associated with acute COVID -19 pneumonia in recipients with solid organ transplantation
As of May 14, 2020, the World Health Organization has reported approximately 4.3 million cases of the novel Coronavirus Disease (COVID-19) with approximately 294,046 deaths worldwide [1]. Solid organ transplant recipients who are on chronic immunosuppressants fall within a special population of COVI...
Autores principales: | Antony, Suresh J., Singh, Joya, de Jesus, Mikhail, Lance, Jessalyn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318948/ https://www.ncbi.nlm.nih.gov/pubmed/32685369 http://dx.doi.org/10.1016/j.idcr.2020.e00888 |
Ejemplares similares
-
Pneumocystis Pneumonia in Solid-Organ Transplant Recipients
por: Iriart, Xavier, et al.
Publicado: (2015) -
Respiratory Viruses in Solid Organ Transplant Recipients
por: Bitterman, Roni, et al.
Publicado: (2021) -
Early use of tocilizumab in solid organ transplant recipients with COVID‐19: A retrospective cohort study in Saudi Arabia
por: Yamani, Amani H., et al.
Publicado: (2022) -
Infections in Solid-Organ Transplant Recipients
por: Singh, Nina, et al.
Publicado: (2015) -
Influenza and other respiratory virus infections in solid organ transplant recipients
por: Manuel, O., et al.
Publicado: (2014)